Camber Capital Management

Latest statistics and disclosures from Camber Capital Management's latest quarterly 13F-HR filing:

Companies in the Camber Capital Management portfolio as of September 2017 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
SPDR S&P; 500 ETF (SPY) 23.93 1.50M +50% 251.23
Nektar Therapeutics (NKTR) 7.93 5.20M -2% 24.00
Tenet Healthcare Corporation stock 6.00 5.75M +43% 16.43
Mylan Nv 5.38 2.70M -36% 31.37
Perrigo Company 5.24 975000 NEW 84.65
Genomic Health (GHDX) 5.01 2.46M 32.09
Myriad Genetics (MYGN) 4.60 2.00M -33% 36.18
Envision Healthcare 4.28 1.50M +328% 44.95
Orthofix International Nv Com Stk 4.13 1.38M -8% 47.25
HCA HOLDINGS Inc 4.04 800000 NEW 79.59
Sarepta Therapeutics 4.03 1.40M +7% 45.36
Brookdale Senior Living (BKD) 3.64 5.40M 10.60
Bioverativ Inc Com equity 3.62 1000000 -14% 57.07
Tesaro 3.28 400000 NEW 129.10
AMAG Pharmaceuticals (AMAG) 3.10 2.65M +55% 18.45
Radius Health 2.82 1.15M +1050% 38.55
Gilead Sciences (GILD) 2.57 500000 -87% 81.02
Endologix (ELGX) 2.27 8.00M +6% 4.46
Invitae 1.43 2.40M 9.37
BioScrip (BIOS) 1.10 6.30M -38% 2.75
Clovis Oncology 1.05 200000 NEW 82.40
Atara Biotherapeutics 0.56 535500 16.55
Biolase Technology (BLTI) 0.00 7.17M 0.00

Past 13F-HR SEC Filings by Camber Capital Management

View All Filings